Trial record 10 of 126 for:    fibromyalgia | Open Studies | Interventional Studies

Effect of Low-impact Aerobic Exercise and Music Therapy in Fibromyalgia (EffMusFibro)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by University of Valencia
Sponsor:
Information provided by (Responsible Party):
GEMMA V ESPÍ LÓPEZ, PhD, University of Valencia
ClinicalTrials.gov Identifier:
NCT02516761
First received: August 4, 2015
Last updated: August 5, 2015
Last verified: August 2015
  Purpose

The idea of this study is the combination of these two techniques (low-impact aerobic exercise through functional movements and music therapy) that have proven to be effective separately. The main objective of this study is to test this combination to reduce widespread pain in fibromyalgia patients, improve their balance, influence on decreasing levels of depression and improve quality of life.


Condition Intervention
Fibromyalgia
Other: Low-impact aerobic exercise combined with music therapy
Other: Low-impact aerobic exercise
Other: Control group

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of Low-impact Aerobic Exercise Combined With Music Therapy in Patients With Fibromyalgia

Resource links provided by NLM:


Further study details as provided by University of Valencia:

Primary Outcome Measures:
  • General discomfort. [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]
    General discomfort, using the Faces Pain Scale. This scale assesses in a global way widespread pain of patients. It values from 0 to 10 on a scale of facial expression (0 = no pain and smiling face, up to 10 = worst possible pain and sad face). The reliability coefficient for this scale is Cohen = 0.61.


Secondary Outcome Measures:
  • Depression. [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]
    By Beck Depression Inventory. This scale aims to assess depression and its somatic intensity by 21 different items assessing depressive symptoms. It includes four answer options arranged from lowest to highest severity. This version is adapted to Spanish and validated and has an internal consistency with Cronbach's alpha coefficient = 0.83. The scale emphasizes more on the cognitive component of depression (15 items), being the symptoms of somatic / vegetative type the second most important group (6 items). The result of 0-9 points means that there is no depression, 10 to 18 points mild depression, 19-29 moderate depression and 30 points indicates severe depression.

  • Impact on quality of life. [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]
    The Fibromyalgia Impact Questionnaire (FIQ).It is a multidimensional self-administered questionnaire with 10 items that evaluates the status of the patient the week before the test is filled, and it assesses the aspects that tend to be more affected in people with fibromyalgia. The first item contains 10 sub-items, ranging from 4 points (from = always to 3 = never) and assesses the patient's functional capacity in activities of daily living. The second and third item refers to days of the week and the rest are visual analog scales from 0 to 10. This scale was validated in its Spanish version in 2013, obtaining a Cronbach coefficient= 0.95.

  • Balance. [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]
    Evaluated by the Berg Scale. Scale on which the balance is evaluated and consists of 14 items, which assess the change of position from sitting to standing position, as well as standing and sitting position without assistance, transfers, standing with eyes closed, feet together, one foot advanced, one leg support, inclination of the body, the ability to pick up an object from the floor and also to turn around (to look back only, or giving a full turn). The internal consistency of the questionnaire is alpha 0.98 and test-retest reliability of 0.98 with a range of 0.86 to 0.99 for individual items.


Estimated Enrollment: 26
Study Start Date: July 2015
Estimated Study Completion Date: September 2015
Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Low-impact aerobic exercise combined with music therapy
Intervention consists in working the muscles which are mostly affected by fibromyalgia through group exercises, which are dynamic, smooth and aim functionality. This exercise is done to the rhythm of melodic music, adapted to the tastes of the participants and also adapted on the way to perform the exercise.
Other: Low-impact aerobic exercise combined with music therapy
Intervention consists in working the muscles which are mostly affected by fibromyalgia through group exercises, which are dynamic, smooth and aim functionality. Each session consists of 60 minutes with 3 parts: initial warming up time, main part through games, group dynamics and pure aerobic workout, and final cool down with stretching. This exercise is done to the rhythm of melodic music, adapted to the tastes of the participants and also adapted on the way to perform the exercise. For this, they were shown a list of 100 music compositions from which participants choose a minimum of 20 preferences. All exercises are performed with proper postural control both dissociated and global and within a framework of therapeutic proprioceptive gymnastics.
Experimental: Low-impact aerobic exercise
Then intervention is like the previous group but with the difference that physical activity is not performed to the rhythm of chosen melodic music. Therefore, exercises are done with general chill-out music throughout the session, without adaptation of the exercise to the music.
Other: Low-impact aerobic exercise
Low-impact aerobic exercise. Then intervention is like the previous group but with the difference that physical activity is not performed to the rhythm of chosen melodic music. Therefore, exercises are done with general chill-out music throughout the session, without adaptation of the exercise to the music.
Active Comparator: Control group
With this group no intervention is done, but they are assessed like the other groups.
Other: Control group
With this group no intervention is done, but they are assessed like the other groups.

Detailed Description:

Material and methods Patients The sample includes volunteer subjects diagnosed with fibromyalgia from the Valencian Association of People Affected by Fibromyalgia that were submitted to participate in the study.

Study design It is a quasi-experimental, longitudinal, prospective, controlled, randomized, single-blinded research. The sample was divided into 3 groups. Patients signed informed consent and then the randomization of subjects to the different study groups was done through computer software by an external assistant who was blinded to the study objectives. The study was conducted in morning and afternoon sessions.

All those patients who belong to the experimental group 1 or 2 attend their sessions which last 60 minutes and are held 2 times a week every other day. The experimental group 1 attends classes in the morning, while the experimental group 2 attends them in the evenings. The control group only comes to the evaluation sessions without doing any particular activity. The subjects are evaluated in two stages, at baseline and after completion of the study.

Intervention Group 1 (G1): Low-impact aerobic exercise combined with music therapy. Intervention consists in working the muscles which are mostly affected by fibromyalgia through group exercises, which are dynamic, smooth and aim functionality.

Group 2 (G2): Low-impact aerobic exercise. Then intervention is like the previous group but with the difference that physical activity is not performed to the rhythm of chosen melodic music. Therefore, exercises are done with general chill-out music throughout the session, without adaptation of the exercise to the music.

Control group (CG): With this group no intervention is done, but they are assessed like the other groups.

Evaluation:

Depression, by Beck Depression Inventory, General discomfort, using the Faces Pain Scale, Balance, evaluated by the Berg Scale.

  Eligibility

Ages Eligible for Study:   30 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • To be between 30 and 80 years old.
  • Meet the new diagnostic criteria for fibromyalgia of the ACR..
  • Meet some or several of the following characteristics:

    • Depression
    • Anxiety
    • Muscle pain
    • Fatigue
    • Sleep disturbance
  • May have limited mobility as long as it is caused by fibromyalgia.

Exclusion Criteria:

  • Medical contraindication for physical activity (locomotor disorder, uncontrolled cardiovascular disease, ...)
  • Deafness or limited hearing
  • Vestibular disorders that compromise balance.
  • Very low visibility or blind people.
  • Psychiatric disorders or excessive emotional tension that could alter the dynamics of the study (psychotic disorder)
  • Cognitive disabilities
  • Decompensation or changes in medication.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02516761

Contacts
Contact: Gemma V Espí-López, Ph D 46651948635 gemma.espi@uv.es
Contact: Gemma V EE, PhD 46651948635 gemma.espi@uv.es

Locations
Spain
Gemma V. Espí López Recruiting
Valencia, Spain, 46010
Contact: Gemma V Espí-López, PhD    46651948635    gemma.espi@uv.es   
Sponsors and Collaborators
University of Valencia
Investigators
Study Director: Gemma V gemma.espi@uv.es, P Department of Physiotherapy
  More Information

Publications:
Responsible Party: GEMMA V ESPÍ LÓPEZ, PhD, Ph, D, University of Valencia
ClinicalTrials.gov Identifier: NCT02516761     History of Changes
Other Study ID Numbers: ID011
Study First Received: August 4, 2015
Last Updated: August 5, 2015
Health Authority: Spain: Ethics Committee

Keywords provided by University of Valencia:
Fibromyalgia

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on August 27, 2015